AI 탑재형 차세대 페이스메이커 시장 : 시장 분석 및 예측 - 유형별, 제품별, 서비스별, 기술별, 컴포넌트별, 용도별, 도입 방식별, 최종 사용자별, 기능별, 솔루션별(-2035년)

The global Next Gen Pacemakers with AI Market is projected to grow from $485.1 million in 2025 to $677.1 million by 2035, at a compound annual growth rate (CAGR) of 3.4%. The Next-Gen Pacemakers with AI Market is gaining momentum as artificial intelligence and machine learning become increasingly integrated into medical-device development and cardiovascular technologies. The U.S. Food and Drug Administration (FDA) maintains an AI/ML-enabled medical device list that demonstrates growing use of these technologies across multiple medical specialties, including cardiovascular applications. FDA's AI program also highlights applications such as identifying patterns in human physiology, supporting diagnosis and risk assessment, and enabling personalized medical decision-making. These developments create opportunities to incorporate advanced data analysis and decision-support capabilities into cardiac pacing systems, supporting continued innovation toward more intelligent, connected, and data-driven pacemaker technologies.

The Type segment of the Next Gen Pacemakers with AI Market includes Implantable Pacemakers, External Pacemakers, Leadless Pacemakers, and Others. Implantable Pacemakers dominated the market in 2025 due to their established clinical use, long-term cardiac rhythm management capabilities, and increasing integration of AI-enabled monitoring and adaptive pacing technologies. Their ability to continuously monitor cardiac activity and automatically adjust pacing parameters supports growing adoption. Leadless Pacemakers are expected to be the fastest-growing segment during the forecast period, driven by their minimally invasive implantation, reduced risk of lead-related complications, compact design, and advancements in AI-enabled cardiac monitoring. Increasing demand for smaller, smarter, and patient-specific pacing technologies is expected to further accelerate adoption.

The End User segment of the Next Gen Pacemakers with AI Market includes Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Home Care Settings, and Others. Hospitals dominated the market in 2025 due to their advanced cardiac-care infrastructure, availability of specialized cardiologists, high volume of pacemaker implantation procedures, and access to sophisticated AI-enabled cardiac technologies. Home Care Settings are expected to be the fastest-growing segment during the forecast period, supported by the increasing adoption of remote patient monitoring, connected pacemakers, and AI-based detection of abnormal cardiac patterns. Remote monitoring enables healthcare providers to track patients outside clinical settings, improving follow-up care and potentially reducing unnecessary hospital visits.

Geographical Overview

North America was the leading region in the Next Gen Pacemakers with AI Market in 2025, supported by advanced cardiac healthcare infrastructure, high adoption of implantable cardiac devices, strong reimbursement frameworks, and rapid integration of AI-enabled monitoring and analytics. The United States accounted for a substantial share of regional demand, supported by a large population with cardiovascular and rhythm disorders, extensive cardiac-care networks, and strong investment in next-generation medical-device technologies. The presence of major pacemaker manufacturers and technology developers, together with growing adoption of remote monitoring, leadless pacing, predictive analytics, and connected cardiac devices, further supported the regional market.

Asia-Pacific is expected to be the fastest-growing region in the Next Gen Pacemakers with AI Market during the forecast period, driven by rising cardiovascular disease prevalence, an aging population, expanding healthcare infrastructure, and increasing access to advanced cardiac rhythm-management technologies. China, India, Japan, South Korea, and Australia are expected to contribute significantly to regional expansion as hospitals and cardiac centers increasingly adopt leadless pacemakers, remote monitoring platforms, connected devices, and AI-supported cardiac management solutions. Growing healthcare investments, improving reimbursement and access to cardiac care, and the expansion of domestic medical-device manufacturing are expected to further support the adoption of next-generation pacemaker technologies across the region.

Key Trends and Drivers

AI-Enabled Adaptive and Closed-Loop Pacing:

The Next-Gen Pacemakers with AI Market is trending toward AI-enabled adaptive pacing systems that continuously interpret intracardiac electrical signals, physiological parameters, and patient activity to optimize pacing in real time. Machine learning and closed-loop algorithms are being developed to improve arrhythmia detection, distinguish true atrial high-rate events from noise, and dynamically adjust pacing parameters according to changing physiological conditions. Recent research is also exploring reinforcement learning and personalized models for self-adjusting cardiac-device therapy. Existing closed-loop stimulation technologies already demonstrate automated beat-to-beat rate adaptation, providing a foundation for increasingly intelligent pacemakers that can personalize therapy while reducing unnecessary pacing.

Demand for Personalized and Remote Cardiac Rhythm Management:

A major driver for the Next-Gen Pacemakers with AI Market is the growing need for personalized pacing, continuous arrhythmia surveillance, and remote management of implanted cardiac devices. Conventional programming can require periodic clinical adjustments, whereas AI-enabled systems can analyze continuously collected cardiac and physiological data to identify changing rhythm patterns and support more individualized pacing strategies. The increasing volume of remote-monitoring transmissions is also creating a need for automated AI systems capable of prioritizing clinically meaningful events and reducing unnecessary alerts. A 2025 multicenter analysis showed AI could process large volumes of CIED transmissions while maintaining high accuracy, highlighting its potential to reduce the workload associated with remote device monitoring.

Research Scope

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Services
• 2.4 Key Market Highlights by Technology
• 2.5 Key Market Highlights by Component
• 2.6 Key Market Highlights by Application
• 2.7 Key Market Highlights by End User
• 2.8 Key Market Highlights by Functionality
• 2.9 Key Market Highlights by Deployment
• 2.10 Key Market Highlights by Solutions

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Implantable Pacemakers
  • 4.1.2 External Pacemakers
  • 4.1.3 Leadless Pacemakers
  • 4.1.4 Others
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Single Chamber Pacemakers
  • 4.2.2 Dual Chamber Pacemakers
  • 4.2.3 Biventricular Pacemakers
  • 4.2.4 Others
• 4.3 Market Size & Forecast by Services (2020-2035)
  • 4.3.1 Remote Monitoring
  • 4.3.2 Consultation Services
  • 4.3.3 Maintenance Services
  • 4.3.4 Others
• 4.4 Market Size & Forecast by Technology (2020-2035)
  • 4.4.1 Artificial Intelligence
  • 4.4.2 Machine Learning
  • 4.4.3 Deep Learning
  • 4.4.4 Cloud Computing
  • 4.4.5 Internet of Things (IoT)
  • 4.4.6 Others
• 4.5 Market Size & Forecast by Component (2020-2035)
  • 4.5.1 Microprocessors
  • 4.5.2 Sensors
  • 4.5.3 Batteries
  • 4.5.4 Software
  • 4.5.5 Others
• 4.6 Market Size & Forecast by Application (2020-2035)
  • 4.6.1 Bradycardia
  • 4.6.2 Heart Failure
  • 4.6.3 Arrhythmias
  • 4.6.4 Others
• 4.7 Market Size & Forecast by End User (2020-2035)
  • 4.7.1 Hospitals
  • 4.7.2 Ambulatory Surgical Centers
  • 4.7.3 Specialty Clinics
  • 4.7.4 Home Care Settings
  • 4.7.5 Others
• 4.8 Market Size & Forecast by Functionality (2020-2035)
  • 4.8.1 Rate-Responsive Pacemakers
  • 4.8.2 Adaptive Pacemakers
  • 4.8.3 Others
• 4.9 Market Size & Forecast by Deployment (2020-2035)
  • 4.9.1 On-Premise
  • 4.9.2 Cloud-Based
  • 4.9.3 Hybrid
  • 4.9.4 Others
• 4.10 Market Size & Forecast by Solutions (2020-2035)
  • 4.10.1 Cardiac Rhythm Management
  • 4.10.2 Remote Patient Monitoring
  • 4.10.3 Data Analytics
  • 4.10.4 Others

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Services
    • 5.2.1.4 Technology
    • 5.2.1.5 Component
    • 5.2.1.6 Application
    • 5.2.1.7 End User
    • 5.2.1.8 Functionality
    • 5.2.1.9 Deployment
    • 5.2.1.10 Solutions
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Services
    • 5.2.2.4 Technology
    • 5.2.2.5 Component
    • 5.2.2.6 Application
    • 5.2.2.7 End User
    • 5.2.2.8 Functionality
    • 5.2.2.9 Deployment
    • 5.2.2.10 Solutions
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Services
    • 5.2.3.4 Technology
    • 5.2.3.5 Component
    • 5.2.3.6 Application
    • 5.2.3.7 End User
    • 5.2.3.8 Functionality
    • 5.2.3.9 Deployment
    • 5.2.3.10 Solutions
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Services
    • 5.3.1.4 Technology
    • 5.3.1.5 Component
    • 5.3.1.6 Application
    • 5.3.1.7 End User
    • 5.3.1.8 Functionality
    • 5.3.1.9 Deployment
    • 5.3.1.10 Solutions
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Services
    • 5.3.2.4 Technology
    • 5.3.2.5 Component
    • 5.3.2.6 Application
    • 5.3.2.7 End User
    • 5.3.2.8 Functionality
    • 5.3.2.9 Deployment
    • 5.3.2.10 Solutions
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Services
    • 5.3.3.4 Technology
    • 5.3.3.5 Component
    • 5.3.3.6 Application
    • 5.3.3.7 End User
    • 5.3.3.8 Functionality
    • 5.3.3.9 Deployment
    • 5.3.3.10 Solutions
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Services
    • 5.4.1.4 Technology
    • 5.4.1.5 Component
    • 5.4.1.6 Application
    • 5.4.1.7 End User
    • 5.4.1.8 Functionality
    • 5.4.1.9 Deployment
    • 5.4.1.10 Solutions
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Services
    • 5.4.2.4 Technology
    • 5.4.2.5 Component
    • 5.4.2.6 Application
    • 5.4.2.7 End User
    • 5.4.2.8 Functionality
    • 5.4.2.9 Deployment
    • 5.4.2.10 Solutions
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Services
    • 5.4.3.4 Technology
    • 5.4.3.5 Component
    • 5.4.3.6 Application
    • 5.4.3.7 End User
    • 5.4.3.8 Functionality
    • 5.4.3.9 Deployment
    • 5.4.3.10 Solutions
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Services
    • 5.4.4.4 Technology
    • 5.4.4.5 Component
    • 5.4.4.6 Application
    • 5.4.4.7 End User
    • 5.4.4.8 Functionality
    • 5.4.4.9 Deployment
    • 5.4.4.10 Solutions
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Services
    • 5.4.5.4 Technology
    • 5.4.5.5 Component
    • 5.4.5.6 Application
    • 5.4.5.7 End User
    • 5.4.5.8 Functionality
    • 5.4.5.9 Deployment
    • 5.4.5.10 Solutions
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Services
    • 5.4.6.4 Technology
    • 5.4.6.5 Component
    • 5.4.6.6 Application
    • 5.4.6.7 End User
    • 5.4.6.8 Functionality
    • 5.4.6.9 Deployment
    • 5.4.6.10 Solutions
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Services
    • 5.4.7.4 Technology
    • 5.4.7.5 Component
    • 5.4.7.6 Application
    • 5.4.7.7 End User
    • 5.4.7.8 Functionality
    • 5.4.7.9 Deployment
    • 5.4.7.10 Solutions
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Services
    • 5.5.1.4 Technology
    • 5.5.1.5 Component
    • 5.5.1.6 Application
    • 5.5.1.7 End User
    • 5.5.1.8 Functionality
    • 5.5.1.9 Deployment
    • 5.5.1.10 Solutions
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Services
    • 5.5.2.4 Technology
    • 5.5.2.5 Component
    • 5.5.2.6 Application
    • 5.5.2.7 End User
    • 5.5.2.8 Functionality
    • 5.5.2.9 Deployment
    • 5.5.2.10 Solutions
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Services
    • 5.5.3.4 Technology
    • 5.5.3.5 Component
    • 5.5.3.6 Application
    • 5.5.3.7 End User
    • 5.5.3.8 Functionality
    • 5.5.3.9 Deployment
    • 5.5.3.10 Solutions
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Services
    • 5.5.4.4 Technology
    • 5.5.4.5 Component
    • 5.5.4.6 Application
    • 5.5.4.7 End User
    • 5.5.4.8 Functionality
    • 5.5.4.9 Deployment
    • 5.5.4.10 Solutions
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Services
    • 5.5.5.4 Technology
    • 5.5.5.5 Component
    • 5.5.5.6 Application
    • 5.5.5.7 End User
    • 5.5.5.8 Functionality
    • 5.5.5.9 Deployment
    • 5.5.5.10 Solutions
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Services
    • 5.5.6.4 Technology
    • 5.5.6.5 Component
    • 5.5.6.6 Application
    • 5.5.6.7 End User
    • 5.5.6.8 Functionality
    • 5.5.6.9 Deployment
    • 5.5.6.10 Solutions
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Services
    • 5.6.1.4 Technology
    • 5.6.1.5 Component
    • 5.6.1.6 Application
    • 5.6.1.7 End User
    • 5.6.1.8 Functionality
    • 5.6.1.9 Deployment
    • 5.6.1.10 Solutions
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Services
    • 5.6.2.4 Technology
    • 5.6.2.5 Component
    • 5.6.2.6 Application
    • 5.6.2.7 End User
    • 5.6.2.8 Functionality
    • 5.6.2.9 Deployment
    • 5.6.2.10 Solutions
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Services
    • 5.6.3.4 Technology
    • 5.6.3.5 Component
    • 5.6.3.6 Application
    • 5.6.3.7 End User
    • 5.6.3.8 Functionality
    • 5.6.3.9 Deployment
    • 5.6.3.10 Solutions
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Services
    • 5.6.4.4 Technology
    • 5.6.4.5 Component
    • 5.6.4.6 Application
    • 5.6.4.7 End User
    • 5.6.4.8 Functionality
    • 5.6.4.9 Deployment
    • 5.6.4.10 Solutions
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Services
    • 5.6.5.4 Technology
    • 5.6.5.5 Component
    • 5.6.5.6 Application
    • 5.6.5.7 End User
    • 5.6.5.8 Functionality
    • 5.6.5.9 Deployment
    • 5.6.5.10 Solutions

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 Medtronic
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Abbott Laboratories
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Boston Scientific
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Biotronik
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 MicroPort Scientific
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 LivaNova
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Sorin Group
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 St Jude Medical
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Ebr Systems
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 BioTelemetry
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Cardiac Science
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Zoll Medical
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Pacetronix
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Shree Pacetronix
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 Osypka Medical
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 Lepu Medical
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 Shenzhen Mindray Bio-Medical Electronics
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 Medico S.p.A
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 Cook Medical
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Oscor
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us